+1 Recommend
1 collections
      • Record: found
      • Abstract: found
      • Article: found

      Growth Failure in Early Life: An Important Manifestation of Turner Syndrome

      Read this article at

          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.


          The goals of this study were to test the hypothesis that girls with Turner syndrome (TS) experience growth failure early in life and to establish model-based normative growth charts for 0- to 8-year-old American girls with TS. Full-term girls with TS who had 5 or more measurements of height obtained during their first 10 years of life prior to initiation of growth hormone, estrogen and/or androgen therapy were eligible for this study. A nonlinear mixed-effects model comprising the first two components of the infancy-childhood-puberty (ICP) model of growth was fitted to the longitudinal height measurements and compared with those of healthy American girls. Height measurements (n = 1,146) from 112 girls with TS (45,X: 57.1%; 45,X/46,XX: 12.5%; 46,X, iso(X): 4.5%, and other: 25.9%) were analyzed. Mean height SDS fell from –0.68 at birth to –1.60 at 1 year, –1.80 at 2 years and –1.95 at 3 years. When compared to controls (676 girls, 4,537 measurements), girls with TS grew more slowly due to three principal factors: a slow growth rate of the infancy component, a slow growth rate at the onset of the childhood component, and delayed onset of the childhood component. Traditional concepts of growth failure in TS should be revised. Physicians should consider the diagnosis of TS in any girl with unexplained failure to thrive or short stature, even in the first 3 years of life.

          Related collections

          Most cited references 4

          • Record: found
          • Abstract: not found
          • Article: not found

          Turner's syndrome.

           P Saenger (1996)
            • Record: found
            • Abstract: not found
            • Article: not found

            Spontaneous Pubertal Development in Turner's Syndrome

             A Pasquino (1997)
              • Record: found
              • Abstract: found
              • Article: not found

              Longitudinal analysis of growth over the first 3 years of life in Turner's syndrome.

               L Even,  A. Cohen,  N Marbach (2000)
              To evaluate longitudinal growth in Turner's syndrome (TS) over the first 3 years of life.

                Author and article information

                Horm Res Paediatr
                Hormone Research in Paediatrics
                S. Karger AG
                30 May 2002
                : 57
                : 5-6
                : 157-164
                aDepartment of Pediatrics, Division of Pediatric Endocrinology and bDepartment of Biostatistics, School of Public Health, The University of North Carolina at Chapel Hill, N.C.; cDivision of Endocrinology and Diabetes, Children’s Hospital and Regional Medical Center and dDivision of Dermatology, University of Washington, Seattle, Wash., USA and ePediatric Endocrinology Unit, Department of Woman and Child Health, Karolinska Institute, Stockholm, Sweden
                58376 Horm Res 2002;57:157–164
                © 2002 S. Karger AG, Basel

                Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher. Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug. Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.

                Page count
                Figures: 4, Tables: 3, References: 37, Pages: 8
                Original Paper


                Comment on this article